Esperion to Participate in Upcoming Virtual J.P. Morgan 40th Annual Healthcare Conference
January 06 2022 - 8:00AM
Esperion (NASDAQ: ESPR) today announced that President and Chief
Executive Officer, Sheldon Koenig, will present at the upcoming
virtual J.P. Morgan 40th Annual Healthcare Conference on Thursday,
January 13, 2022 at 10:30 a.m. Eastern Time.
Event: |
J.P. Morgan
40th Annual Healthcare Conference |
Date: |
Thursday, January 13, 2022 |
Format: |
Presentation and 1:1 Meetings |
Time: |
10:30 a.m. ET |
Live audio webcasts of these events can be accessed on the
investor relations section of the Esperion website at
www.esperion.com/investors-media/events-presentations/. Replays of
the webcasts will be archived on the Company's website for 90 days
following the events.
Esperion Therapeutics
Esperion is The Lipid Management Company. Our goal is lipid
management for everybody, that’s why we work hard to make our
medicines easy to get, easy to take and easy to have. We discover,
develop and commercialize innovative medicines and combinations to
lower cholesterol, especially for patients whose needs aren’t being
met by the status quo. Our entrepreneurial team of industry leaders
is inclusive, passionate and resourceful. For more information,
please visit www.esperion.com and follow us on Twitter at
www.twitter.com/EsperionInc.
Investor Contact:Kaitlyn
BroscoEsperioncorporateteam@esperion.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024